Authors:
BJORGE L
JUNNIKKALA S
KRISTOFFERSEN EK
HAKULINEN J
MATRE R
MERI S
Citation: L. Bjorge et al., RESISTANCE OF OVARIAN TERATOCARCINOMA CELL SPHEROIDS TO COMPLEMENT-MEDIATED LYSIS, British Journal of Cancer, 75(9), 1997, pp. 1247-1255
Authors:
BJORGE L
JENSEN TS
KRISTOFFERSEN EK
ULSTEIN M
MATRE R
Citation: L. Bjorge et al., IDENTIFICATION OF THE COMPLEMENT REGULATORY PROTEIN CD59 IN HUMAN COLOSTRUM AND MILK, American journal of reproductive immunology [1989], 35(1), 1996, pp. 43-50
Citation: L. Bjorge et al., CHARACTERIZATION OF THE COMPLEMENT-REGULATORY PROTEINS DECAY-ACCELERATING FACTOR (DAF,CD55) AND MEMBRANE COFACTOR PROTEIN (MCP,CD46) ON A HUMAN COLONIC ADENOCARCINOMA CELL-LINE, Cancer immunology and immunotherapy, 42(3), 1996, pp. 185-192
Citation: Ts. Jensen et al., IDENTIFICATION OF THE COMPLEMENT REGULATORY PROTEINS CD46, CD55, AND CD59 IN HUMAN FALLOPIAN-TUBE, ENDOMETRIUM, AND CERVICAL MUCOSA AND SECRETION, American journal of reproductive immunology [1989], 34(1), 1995, pp. 1-9
Citation: L. Bjorge et R. Matre, DOWN-REGULATION OF CD59 (PROTECTIN) EXPRESSION ON HUMAN COLORECTAL ADENOCARCINOMA CELL-LINES BY LEVAMISOLE, Scandinavian journal of immunology, 42(5), 1995, pp. 512-516
Authors:
BJORGE L
JENSEN TS
ULVESTAD E
VEDELER CA
MATRE R
Citation: L. Bjorge et al., THE INFLUENCE OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-1-BETA AND INTERFERON-GAMMA ON THE EXPRESSION AND FUNCTION OF THE COMPLEMENT REGULATORY PROTEIN CD59 ON THE HUMAN COLONIC ADENOCARCINOMA CELL-LINE HT29, Scandinavian journal of immunology, 41(4), 1995, pp. 350-356
Citation: L. Bjorge et al., EXPRESSION AND FUNCTION OF CD59 ON COLONIC ADENOCARCINOMA CELLS, European Journal of Immunology, 24(7), 1994, pp. 1597-1603